Juliana Almeida Leite
Biographic Data
| ID | 10243391 |
|---|---|
| NAME | Juliana Almeida Leite |
| GIVEN NAMES | Juliana Almeida |
| FAMILY NAME | Leite |
| SIGNATURE | LEITE J A |
| AFFILIATIONS | World Health Organization Regional Office for the Americas |
| ORCID | 0000-0002-8620-114X |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Overview of Sars-CoV-2 genomic surveillance in Central America and the Dominican Republic from February 2020 to January 2023
This study provides a comprehensive overview of SARS-CoV-2 genomic surveillance in Central America and the Dominican Republic from February 2020 to January 2023, highlighting the collaborative efforts of the Pan American Health Organization (PAHO), and the Council of Ministers of Health of Central America (COMISCA). A total of 26,595 sequences from the GISAID database were analyzed, correlating findings with key events reported by participating e…
Strengthening pathogen genomic surveillance for health emergencies
The onset of the COVID-19 pandemic triggered a rapid scale-up in the use of genomic surveillance as a pandemic preparedness and response tool. As a result, the number of countries with in-country SARS-CoV-2 genomic sequencing capability increased by 40% from February 2021 to July 2022. The Global Genomic Surveillance Strategy for Pathogens with Pandemic and Epidemic Potential 2022–2032 was launched by the World Health Organization (WHO) in March …
No prominent works on this page.
Strengthening pathogen genomic surveillance for health emergencies
The onset of the COVID-19 pandemic triggered a rapid scale-up in the use of genomic surveillance as a pandemic preparedness and response tool. As a result, the number of countries with in-country SARS-CoV-2 genomic sequencing capability increased by 40% from February 2021 to July 2022. The Global Genomic Surveillance Strategy for Pathogens with Pandemic and Epidemic Potential 2022–2032 was launched by the World Health Organization (WHO) in March …
Overview of Sars-CoV-2 genomic surveillance in Central America and the Dominican Republic from February 2020 to January 2023
This study provides a comprehensive overview of SARS-CoV-2 genomic surveillance in Central America and the Dominican Republic from February 2020 to January 2023, highlighting the collaborative efforts of the Pan American Health Organization (PAHO), and the Council of Ministers of Health of Central America (COMISCA). A total of 26,595 sequences from the GISAID database were analyzed, correlating findings with key events reported by participating e…
Public health (2 works) · Public health surveillance (2 works) · SARS-CoV-2 and COVID-19 Research (2 works) · SARS-CoV-2 detection and testing (2 works) · Bacillus and Francisella bacterial research (1 works) · Business (1 works) · Disease (1 works) · Economic shortage (1 works) · Genetic diversity (1 works) · Genomics and Rare Diseases (1 works)